A New Method for Measuring Progression in Patients with Ocular Cicatricial Pemphigoid

Archives of Ophthalmology

Volumn 122, Issue 2, 2004, Pages 179-184

  Rowsey, J James ^a,c   Macias Rodriguez, Yolanda ^b   Cukrowski, Chris ^a  

^a St Luke's Cataract and Laser Institute   (United States)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^c St Luke's Cataract/Laser Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHOTREXATE; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVA; DISEASE COURSE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; MEASUREMENT; MUCOUS MEMBRANE PEMPHIGOID; OCULAR CICATRICIAL PEMPHIGOID; PRIORITY JOURNAL; TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; CONJUNCTIVA; CONJUNCTIVAL DISEASES; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 0842327159     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.2.179     Document Type: Article

References (37)

1. Giuri S. Ocular cicatricial pemphigoid [in Romanian]. Oftalmologia. 1999;47:13-21.
2. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci. 1999;20:134-154.
3. Chan LS. Human skin basement membrane in health and in autoimmune diseases. Front Biosci. 1997;2:D343-D352.
4. Kumari S, Bhol KC, Simmons RK, et al. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human β4 integrin. Invest Ophthalmol Vis Sci. 2001;42:379-385.
5. Egan CA, Yancey KB. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol. 2000;10:585-589.
6. Leverkus M, Schmidt E, Lazarova Z, Brocker EB, Yancey KB, Zillikens D. Anti-epiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol. 1999;135:1091-1098.
7. Zillikens D. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes. Keio J Med. 2002;51:21-28.
8. Kromminga A, Sitaru C, Meyer J, et al. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J Dermatol Sci. 2002;28:68-75.
9. Kirtschig G. Autoantigens of cicatricial pemphigoid and their pathogenetic significance [in German]. Hautarzt. 1998;49:818-825.
10. 3γ2). Br J Dermatol. 1998;139:791-797.
11. Fujimoto W, Toi Y, Okazaki F, Lazarova Z, Yancey KB, Arata J. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5. J Am Acad Dermatol. 1999;40:637-639.
12. Mondino BJ, Manthey R. Dermatological diseases and the peripheral cornea. Int Ophthalmol Clin. 1986;26:121-136.
13. Mondino BJ, Bartly J, Hovanesian J, Pleyer U. Bullous diseases of the skin and mucous membranes. In: Duane, eds. Clinical Ophthalmology [book on CD-ROM]. Vol 4. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:chap 12.
14. Mondino BJ. Cicatricial pemphigoid and erythema multiforme. Ophthalmology. 1990;97:939-952.
15. Razzaque MS, Foster CS, Ahmed AR. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci. 2003;44:1998-2003.
16. Mondino BJ, Brown SI, Lempert S, Jenkins MS. The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology. 1979;86:543-555.
17. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea. 1992;11:446-451.
18. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527-663.
19. Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology. 1981;88:95-100.
20. Holsclaw DS. Ocular cicatricial pemphigoid. Int Ophthalmol Clin. 1998;38:89-106.
21. Messmer EM, Hintschich CR, Partscht K, Messer G, Kampik A. Ocular cicatricial pemphigoid: retrospective analysis of risk factors and complications [in German]. Ophthalmologe. 2000;97:113-120.
22. Elder MJ, Bernauer W, Leonard J, Dart JK. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol. 1996;80:292-296.
23. Baier G, Zillikens D. Cicatricial pemphigoid-an important differential diagnosis in inflammatory mucous membrane changes [in German]. Laryngorhinootologie. 1999;78:632-637.
24. Flach A. Symblepharon in sarcoidosis. Am J Ophthalmol. 1978;85:210-214.
25. Darougar S, Quinlan MP, Gibson JA, Jones BR. Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol. 1977;61:76-85.
26. Bialy-Golan A, Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol. 1996;35(pt 1):732-742.
27. Lass JH, Thoft RA, Dohlman CH. Idoxuridine-induced conjunctival cicatrization. Arch Ophthalmol. 1983;101:747-750.
28. Patten JT, Cavanagh HD, Allansmith MR. Induced ocular pseudopemphigoid. Am J Ophthalmol. 1976;82:272-276.
29. Kubo M, Sakuraba T, Arai Y, Nakazawa M. A case of suspected drug-induced ocular pemphigoid [in Japanese]. Nippon Ganka Gakkai Zasshi. 2001;105:189-192.
30. Pouliquen Y, Patey A, Foster CS, Goichot L, Savoldelli M. Drug-induced cicatricial pemphigoid affecting the conjunctiva: light and electron microscopic features. Ophthalmology. 1986;93:775-783.
31. Fiore PM, Jacobs IH, Goldberg DB. Drug-induced pemphigoid: a spectrum of diseases. Arch Ophthalmol. 1987;105:1660-1663.
32. Rogers RS 3rd, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol. 1982;6:215-223.
33. Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol. 1983;96:453-459.
34. Tauber J, Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea. 1991;10:185-195.
35. Elder MJ, Lightman S, Dart JK. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol. 1995;79:264-266.
36. Bohn J, Jonsson S, Holst R. Successful treatment of recalcitrant cicatricial pemphigoid with a combination of plasma exchange and cyclophosphamide. Br J Dermatol. 1999;141:536-540.
37. Trigui A, Kammoun B, Ghodhbane M, Fourati M, Mseddi M, Chaabouni M. Penetrating keratoplasty in ocular cicatricial pemphigoid [in French]. J Fr Ophtalmol. 2002;25:48-51.